Dengue Hemorrhagic fever under the treatment of the pediatrics ward (2013-2015)

Abstract

Background: Dengue hemorrhagic fever is a global public health problem and also the leading cause of morbidity and mortality among Asian countries. Moreover this disease is also an important health issue of Thailand. The major cause of death is fluid overload with prolonged shock or bleeding. Prompt diagnosis and shock prevention are key issues to decrease the following complications. Researcher therefore conducted this study in order to obtain data for improving patient care
Objective: To review fluid replacement therapy, complication and treatment outcome in pediatric hemorrhagic dengue fever and dengue shock syndrome patient in pediatric care ward, Prakonchai hospital, Prakonchai, Buriram province
Study design: retrospective descriptive study
Methods: retrospective review of patient medical record had been conducted in patient aged below 15 years old diagnosed with dengue hemorrhagic fever or dengue shock syndrome in pediatric care ward, Prakonchai hospital, Prakonchai, Buriram province during January 1st 2013 to December 31st 2015. The review included clinical symptom, laboratory result, fluid replacement therapy, clinical outcome, complications and disease control reporting.
Results: There were 215 pediatric patients diagnosed with dengue hemorrhagic fever and dengue shock syndrome during 2013-2015 in Prakonchai district. Ratio of male to female was 1:1.3 and most of cases aged between 10-14 years (56.9%) seconded by 5-9 years of age (27.9%). There were 18 cases of dengue shock syndrome patient in which 66.7% were female. The most frequent complication was fluid overload (12 cases) and hepatitis (8 cases). Disease control was reported 46% of hospitalized cases and average reporting time was 1.24+1.57 of admission day.
Conclusion: In order to decrease complication of fluid overload and referral rate, physician should provide early diagnosis and appropriate fluid replacement therapy. Reporting system for disease control should be conducted within 24 hour after patient was diagnosed or suspected of dengue fever for effective disease control.